Compare · FLUX vs TMO
FLUX vs TMO
Side-by-side comparison of Flux Power Holdings Inc. (FLUX) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- FLUX operates in Miscellaneous, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $175.70B, about 8478.8x FLUX ($20.7M).
- Over the past year, FLUX is down 35.8% and TMO is up 14.9% - TMO leads by 50.8 points.
- TMO has been more active in the news (17 items in the past 4 weeks vs 11 for FLUX).
- TMO has more recent analyst coverage (25 ratings vs 3 for FLUX).
- Company
- Flux Power Holdings Inc.
- Thermo Fisher Scientific Inc
- Price
- $1.02+5.15%
- $469.56-0.67%
- Market cap
- $20.7M
- $175.70B
- 1M return
- -22.14%
- -1.03%
- 1Y return
- -35.85%
- +14.92%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 11
- 17
- Recent ratings
- 3
- 25
Flux Power Holdings Inc.
Flux Power Holdings, Inc., through its subsidiary Flux Power, Inc., designs, develops, manufactures, and sells lithium-ion energy storage solutions for lift trucks, airport ground support equipment, and other industrial and commercial applications in the United States. It offers battery management system (BMS) that provides cell balancing, charging, discharging, monitoring, and communication between the pack and the forklift. The company also provides 24-volt onboard chargers for its Class 3 Walkie LiFT packs; and smart wall mounted chargers to interface with its BMS. The company sells its products directly to small companies and end-users, as well as through original equipment manufacturers, lift equipment dealers, and battery distributors. Flux Power Holdings, Inc. was incorporated in 1998 and is based in Vista, California.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest FLUX
- SEC Form EFFECT filed by Flux Power Holdings Inc.
- SEC Form 424B3 filed by Flux Power Holdings Inc.
- Director Walters-Hoffert Lisa converted options into 50,000 shares, increasing direct ownership by 113% to 94,107 units (SEC Form 4)
- Director Robinette Dale Thomas converted options into 50,000 shares, increasing direct ownership by 89% to 106,311 units (SEC Form 4)
- Director Leposky Mark F converted options into 50,000 shares, increasing direct ownership by 293% to 67,057 units (SEC Form 4)
- Director Johnson Michael converted options into 50,000 shares, increasing direct ownership by 89% to 106,311 units (SEC Form 4)
- Flux Power Appoints Stuart "Stu" Jacover as Vice President of Sales, Material Handling
- SEC Form D filed by Flux Power Holdings Inc.
- SEC Form S-1 filed by Flux Power Holdings Inc.
- SEC Form 424B3 filed by Flux Power Holdings Inc.
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)